NEUROONE MED TECHNOLOGIES CO COM NEW

NEUROONE MED TECHNOLOGIES CO COM NEW is a security (CUSIP 64130M209) tracked across SEC portfolio filings. 23 institutional managers reported $7.4M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $421K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 23 managers by value.

ManagerLocationValueShares
Bleichroeder LPNEW YORK, NY$3.1M4,000,000
BARD ASSOCIATES INCCHICAGO, IL$1.4M1,840,498
VANGUARD GROUP INCValley Forge, PA$1.2M1,578,237
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$509K655,446
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$478K615,606
Sio Capital Management, LLCNew York, NY$386K496,614
NORTHERN TRUST CORPCHICAGO, IL$87K112,123
CITADEL ADVISORS LLCMIAMI, FL$79K
STATE STREET CORPBOSTON, MA$46K59,499
XTX Topco LtdLONDON, X0$34K43,283
TWO SIGMA SECURITIES, LLCNew York, NY$19K24,764
United Community BankGreenville, SC$16K20,000
Arch Global Advisors, LLCNEW YORK, NY$14K17,434
LPL Financial LLCFORT MILL, SC$12K15,034
MORGAN STANLEYNEW YORK, NY$9K12,096

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$421K0.05%

More